This research briefing from the Health Governance After Brexit project indicates the need for greater transparency to show the implications of the current UK-EU and UK-US trade negotiations for the NHS, and health more generally.
While both negotiations are principally about trade, they have profound implications for health, covering a range of issues from medical product certification and distribution, quality of regulation, and the broader relationship between public and private healthcare providers. This research compares the negotiating positions of parties in both sets of trade negotiations, and evaluates the implications of those positions for health and the NHS. We analysed UK and EU documentation including draft negotiating documents from both sides, and papers detailing the UK’s negotiating position in UK-US trade negotiations, as well as a range of documentary and academic evidence setting out the likely position the US will take in those negotiations.Download Post-Brexit trade negotiations and health governance
The views expressed in this research paper are those of the authors and not necessarily those of the UK in a Changing Europe initiative.